Yes to Recreational Drugs and Complementary Medicines But No to Life-Saving Medications: Beliefs Underpinning Treatment Decisions Among PLHIV

AIDS and Behavior
Amary MeyShailendra Anoopkumar-Dukie

Abstract

Despite the life-preserving benefits of antiretroviral therapy (ART), some people living with HIV (PLHIV) delay, decline or diverge from recommended treatment while paradoxically being willing to use potentially dangerous substances, such as recreational drugs (RD) and complementary medicines (CM). During 2016 and 2017, interviews were conducted with 40 PLHIV, in Australia to understand drivers underpinning treatment decisions. While many believed ART to be effective, they expressed concerns about long-term effects, frustration over perceived lack of autonomy in treatment decisions and financial, emotional and physical burdens of HIV care. In contrast, they ascribed a sense of self-control over the use of RD and CM, along with multiple professed benefits. The perceived burden of ART emerged as a motivator for deviating from recommended treatment, while positive views towards RD and CM appear to justify use. This study may serve as guidance for the development of future strategies to address barriers to treatment uptake and adherence and subsequently health outcomes for PLHIV in Australia and elsewhere.

References

Dec 1, 1996·Family Practice·M N Marshall
Jun 29, 2000·International Journal of STD & AIDS·R S GoldC G Batrouney
Jul 6, 2000·Annals of Internal Medicine·D L PatersonN Singh
Feb 28, 2002·Patient Education and Counseling·Linda FogartyRichard Levy
Jun 23, 2005·International Journal of STD & AIDS·Edward MillsEdzard Ernst
Dec 13, 2005·Sexual Health·K J WilsonC K Fairley
Apr 18, 2007·Annals of Internal Medicine·Jean B NachegaGary Maartens
Mar 20, 2010·AIDS·Valentina CambianoAndrew N Phillips
Aug 4, 2011·Archives of Pediatrics & Adolescent Medicine·Peter FreemanUNKNOWN Adolescent Trials Network for HIV/AIDS Interventions 016b Team
Aug 31, 2011·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Ashli Owen-SmithRalph DiClemente
Mar 16, 2012·Journal of the Royal Society, Interface·Dominique CadoschRoger Kouyos
Sep 3, 2013·AIDS Patient Care and STDs·Ava Lorenc, Nicola Robinson
Nov 7, 2013·Administration and Policy in Mental Health·Lawrence A PalinkasKimberly Hoagwood
Feb 15, 2015·International Journal of STD & AIDS·Lesley A BraunAlison J Duncan
Mar 22, 2015·Clinical Orthopaedics and Related Research·Iain S ElliottR Richard Coughlin
Jun 4, 2015·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Andrew StolbachPaul Pham
May 26, 2016·Journal of Advanced Nursing·Hanna KallioMari Kangasniemi
Sep 16, 2016·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Natalie E Kelso-ChichettoRobert L Cook
Oct 8, 2016·Expert Review of Clinical Pharmacology·Kristina M BrooksParag Kumar
Jun 5, 2018·The Lancet. HIV·Praphan Phanuphak, Nittaya Phanuphak
Dec 15, 2018·HIV Medicine·Erm PoolUNKNOWN Pharmacokinetic and Clinical Observations in People over Fifty (POPPY) study team
Jan 24, 2019·Current HIV/AIDS Reports·LaTrice MontgomeryAngela M Haeny
Feb 2, 2019·Journal of Psychoactive Drugs·Travis S K Kong, Karen Joe Laidler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.